Schedule an Appointment

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.
Book a Conference Call
Get More Information

PlantForm Corporation

Location: Toronto, ON

Sector: Life Sciences

.

Add to Shortlist
Express Interest

PlantForm Corporation is a privately-held Canadian biopharmaceutical company, commercializing a plant-based manufacturing platform, vivoXPRESS®, for the low-cost production of high-value therapeutic drugs. Their pipeline includes biosimilar drugs with a focus on international markets including China, Europe, India, Latin America, MENA as well as major North American and European markets. The company is also developing innovator biologics for niche infectious disease and countermeasures-to-bioterrorism markets. Their pipeline is funded through equity, government grants and contracts from non-profit organizations, such as the Bill & Melinda Gates Foundation.

Business Documents

MG cp Summary

Patented production system (vivoXPRESS®) – The plant based production system produces high quality drugs at very low cost.

 

Unique glycosylation of drugs – Protein and antibody molecules often have carbohydrates (sugars) decorating the surface. PlantForm can create unique structures increasing the efficacy and reducing the dose such protein and antibody drugs.

 

Experienced management team – Veterans in the biotechnology industry having the experience to move the high-value PlantForm investment proposition forward.

PlantForm Corporation is a privately-held Canadian biopharmaceutical company, commercializing a plant-based manufacturing platform, vivoXPRESS®, for the low-cost production of high-value therapeutic drugs. Their pipeline includes biosimilar drugs with a focus on international markets including China, Europe, India, Latin America, MENA as well as major North American and European markets. The company is also developing innovator biologics for niche infectious disease and countermeasures-to-bioterrorism markets. Their pipeline is funded through equity, government grants and contracts from non-profit organizations, such as the Bill & Melinda Gates Foundation.

Don Stewart, CEO

Dr. Don Stewart, an entrepreneur and scientist, is a founder of PlantForm and assumes the roles of President and Chief Executive Officer.  Dr. Stewart brings 30 years’ management experience in the biotechnology industry to this role.  Dr. Stewart has founded and developed companies in the field of biotechnology and in real estate.

 

Ron Hosking, CFO

Mr. Ron Hosking, an experienced financial manager and chartered accountant, is a founder of PlantForm Corporation. Mr. Hosking brings 35 years of experience, providing strong leadership, sound business management and clear strategic financial direction to growing businesses in the life sciences industry.

 

David Cayea, COO

Mr. David Cayea is an entrepreneur who has successfully launched private-sector companies in multiple industries over the last 20 years.  Mr. Cayea joined PlantForm in 2011 as Director of International Relations & Business Development, responsible for advancing the Companies strategic growth strategy by developing and fostering global partnerships. More recently Mr Cayea was appointed to the expanded role of COO of PlantForm.